Analysis and standardization of the new anxiolytic drug afobazole

Author： Milkina S.   Stepanenko O.   Grushevskaya L.   Avdyunina N.   Pyatin B.   Bagirova V.   Nechaeva E.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.40, Iss.7, 2006-07, pp. : 405-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis and standardization of the new domestic antiarrhythmic drug bradizol

By Barteneva E.   Stepanenko O.   Avdyunina N.   Bol’shakova R.   Klimova N.   Ustinova M.   Pyatin B.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 12, 2004-12 ,pp. : 703-706

Springer Publishing Company

Access to resources Recommend Favorite

Analysis and Standardization of the New Psychotropic and Immunotropic Drug Ladasten

By Karavanova D. E.   Pyatin B. M.   Klimova N. V.   Avdyunina N. I.   Stepanenko O. B.   Tsvetkova E. A.   Shamenkova N. V.   Prokof'eva V. I.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 10, 2003-10 ,pp. : 543-546

Springer Publishing Company

Access to resources Recommend Favorite

Pregabalin: a new anxiolytic

By Lauria-Horner Bianca A   Pohl Robert B  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 663-672

Informa Healthcare

Access to resources Recommend Favorite

Neuroendocrine profile of the potential anxiolytic drug S-20499

By Levy A.D.   Li Q.   Gustafson M.   Van de Kar L.D.  

European Journal of Pharmacology, Vol. 274, Iss. 1, 1995-02 ,pp. : 141-149

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Buspirone, an Anxiolytic Drug

By Mahmood I.   Sahajwalla C.  

Clinical Pharmacokinetics, Vol. 36, Iss. 4, 1999-04 ,pp. : 277-287

Adis International

Access to resources Recommend Favorite